The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics.

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Abstract Text:

Rosebud O Roberts,Yonas E Geda,David S Knopman,Ruth H Cha,V Shane Pankratz,Bradley F Boeve,Robert J Ivnik,Eric G Tangalos,Ronald C Petersen,Walter A Rocca,

Background: The objective of this study was to establish a prospective population-based cohort to investigate the prevalence, incidence and risk factors for mild cognitive impairment (MCI) and dementia. Methods: The Olmsted County, Minn., population, aged 70-89 years on October 1, 2004, was enumerated using the Rochester Epidemiology Project. Eligible subjects were randomly selected and invited to participate. Participants underwent a comprehensive in-person evaluation including the Clinical Dementia Rating Scale, a neurological evaluation and neuropsychological testing. A consensus diagnosis of normal cognition, MCI or dementia was made by a panel using previously published criteria. A subsample of subjects was studied via telephone interview. Results: Four hundred and two subjects with dementia were identified from a detailed review of their medical records but were not contacted. At baseline, we successfully evaluated 703 women aged 70-79 years, 769 women aged 80-89 years, 730 men aged 70-79 years and 517 men aged 80-89 years (total n = 2,719). Among the participants, 2,050 subjects were evaluated in person and 669 via telephone. Conclusions: Strengths of the study are that the subjects were randomly selected from a defined population, the majority of the subjects were examined in person, and MCI was defined using published criteria. Here, we report the design and sampling, participation, baseline measures and sample characteristics. Copyright (c) 2008 S. Karger AG, Basel.

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Publishing Authors By Initials

RO Roberts,YE Geda,DS Knopman,RH Cha,VS Pankratz,BF Boeve,RJ Ivnik,EG Tangalos,RC Petersen,WA Rocca,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neuroepidemiology

VOLUME: 30

Page Numbers: 58-69

Journal Abbreviation:

ISSN: 1423-0208

DAY: 7

MONTH: 02

YEAR: 2008

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8218700

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics.

AFFILIATION: Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, Minn., USA.

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neuroepidemiology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics Related Publications

• Aspirin: promise and resistance in the new millennium.
• Chemical exposures and Parkinson's disease: a population-based case-control study.
• Comparative study of floating and dynamic injection modes in electrokinetic separative microsystems.
• Demonstration of a 10-muJ tabletop laser at 52.9 nm in neonlike chlorine.
• Direct medical costs associated with Parkinson's disease: a population-based study.
• Dynamics of converging laser-created plasmas in semicylindrical cavities studied using soft x-ray laser interferometry.
• Electrochromatographic separation on a poly(dimethylsiloxane)/glass chip by integration of a capillary containing an acrylate monolithic stationary phase.
• Electrokinetic-based injection modes for separative microsystems.
• Function approximation-fast-convergence neural approach based on spectral analysis.
• Generation of millijoule-level soft-x-ray laser pulses at a 4-Hz repetition rate in a highly saturated tabletop capillary discharge amplifier.
• Highly coherent injection-seeded 13.2 nm tabletop soft x-ray laser.
• Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.
• Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease.
• Intense plasma discharge source at 13.5 nm for extreme-ultraviolet lithography.
• Multiday recordings from the primary neurons of the statoreceptors of the labyrinth of the bull frog. The effect of an extended period of "weightlessness" on the rate of firing at rest and in response to stimulation by brief periods of centrifugation (OFO
• Number of children and risk of Parkinson's disease.
• Numerical simulations of the second-order electrokinetic bias observed with the gated injection mode in chips.
• Operation and output pulse characteristics of an extremely compact capillary-discharge tabletop soft-x-ray laser.
• PIN Silicon Diodes as EXAFS Signal Detectors.
• Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings.
• Spectroscopically pure metal vapor source for highly charged ion spectroscopy and capillary discharge soft x-ray lasers.
• Synthesis of propyl-functionalized hybrid monolithic silica capillaries and evaluation of their performances in nano-LC and CEC.
• The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics.
• Thirty-five verified cases of cysticercosis of the brain.
• Toward a definition of structural and functional MRI substrates of fatigue in multiple sclerosis.
• [Advances in biologic therapy for inflammatory bowel disease]
• [Brain tumors.]
• [Clinical considerations of hypertrichosis in women.]
• [Historical review of surgery in Peru.]
• [Hypertrichosis and ovarian polycystosis.]